ZhongShan LaiBo RuiChen BioMedicine Co.,Ltd.
ZhongShan LaiBo RuiChen BioMedicine Co.,Ltd.
Explore linked clinical trials.2 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Phase Ib Trial of Injectable RAB001 for Knee Osteoarthritis | arthritic joint disease, arthropathy, musculoskeletal system disorder, osteoarthritis, osteoarthritis, knee, rheumatic disorder | Enrolling by invitation | Phase 1 | 2026-06-17 | NCT07652372 | |
| A Phase II Trial of RAB001 (LLP2A-Alendronate) for Steroid-Induced Early-Stage Osteonecrosis of the Femoral Head | Legg-Calve-Perthes disease, Necrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, bone disorder, familial avascular necrosis of femoral head, musculoskeletal system disorder, osteonecrosis | Active, not recruiting | Phase 2 | 2026-03-24 | NCT07471880 |